analytics_image
Vantage Market Research
Vantage Market Research

Reports - Autologous Cell Therapy Product Market

iconHealthcare

Autologous Cell Therapy Product Market

Autologous Cell Therapy Product Market by Source (Bone Marrow, Epidermis), by End User (Hospitals, Ambulatory Centers, Research Centers), by Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 5.41 Billion

Market Size By 2035

USD 50.35 Billion

CAGR (2025 - 2035)

22.55%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Source, By End User, By Application, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview


Market Synopsis:

Autologous Cell Therapy Product Market Size, 2024 To 2035 (USD Billion)

The global Autologous Cell Therapy Product Market is valued at USD 5.41 Billion in 2024 and is projected to reach a value of USD 50.35 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 22.55% between 2025 and 2035. The increased frequency of chronic diseases such as autoimmune diseases, cancer, blood disorders, and others is one of the primary drivers driving the Autologous Cell Therapy Product industry. The demand for market growth is also being fueled by an increase in the number of people suffering from chronic ailments. According to the American Autoimmune Related Diseases Association (AARDA), around 50 million Americans have an autoimmune disease in 2018, and this number is likely to climb in the future. There are a few more variables that are vital in propelling the Autologous Cell Therapy Product market forward, one of which is ongoing medication development for new applications, which is predicted to further propel the Autologous Cell Therapy Product market forward.

Most businesses have been working on the development of cell-based therapeutics for COVID-19 treatment, the impact of the COVID-19 pandemic on the Autologous Cell Therapy Product market is projected to be enormous. Because most pharmaceutical, biotechnology, and research organisations have been concentrating on the development of cell therapy-based treatment against COVID-19, the impact of COVID-19 is likely to have a beneficial impact on the studied market.

Rising Government Investments in Cell-Based Research

The demand for novel, better medicines for diseases like cancer and cardiovascular disease has led in an increase in general research effort, as well as financing for cell-based research. The Stem Cell Therapies Mission, a 10-year roadmap for stem cell research in Australia, was released by the Australian government in November 2019. Under the Medical Research Future Fund (MRFF), the project would grant USD 102 million (AU$150 million) to encourage stem cell research in order to develop novel medicines. The National Institutes of Health (NIH) has greatly boosted funding for the development of cell treatments in the United States over the years. The good financing situation is boosting demand for Autologous Cell Therapy Product research equipment, media, reagents, and accessories.

Dearth of Skilled Professionals

Despite technological advancements and product development over the last decade, the market has been hampered by a shortage of skilled workers who can operate sophisticated instruments like flow cytometers and multi-mode readers. Flow cytometers and spectrophotometers, which are technologically modern and very complicated, produce a wide range of data outputs that require skill to analyse and review. There remains, nevertheless, a global demand-supply gap for trained people.

Market Segmentation:

Global Autologous Cell Therapy Product market is segmented on the basis of Source into Bone Morrow & Epidermis. By End-User into Hospitals, Ambulatory Centers and Research Centers. By Application into Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD and Autoimmune Diseases. Based on region, the Autologous Cell Therapy Product market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the Autologous Cell Therapy Product Market

North America dominated the Autologous Cell Therapy Product market. The region has experienced great economic growth, has access to cutting-edge technology, and has seen significant corporate and public sector investment. Other factors driving the market in the region include the availability of cutting-edge research infrastructure, the simplicity with which clinical trials may be approved, and a growth in R&D initiatives aimed at developing therapeutic options for chronic diseases. The United States is a big contributor to the countrys key market vendors and research firms. Several pipeline developments in the region are boosting market demand. Celgene and Evotec SE increased their partnership in June 2019 to include a novel iPSC that will now be used to recover disease-modifying medicines for patients with neurological illnesses.

Key Players:

Key participants operating in the Autologous Cell Therapy Product market are: Vericel Corporation (US)

The Autologous Cell Therapy Product market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Source

  • Bone Marrow (58.9%)
  • Epidermis

By End User

  • Hospitals (57.8%)
  • Ambulatory Centers
  • Research Centers

By Application

  • Cancer
  • Neurodegenerative Diseases
  • Wound Healing
  • Orthopedic (17.1%)
  • CVD
  • Autoimmune Diseases

By Region

  • North America (U.S., Canada, Mexico) (38.9%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Vericel Corporation (US)
  • Pharmicell Co. Inc(South Korea)
  • Holostem Terapie Avanzate S.R.L (Italy)
  • Lineage Cell Therapeutics Inc. (US)
  • Opexa Therapeutics (US)
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

The Autologous Cell Therapy Product market scope can be tabulated as below:

Report coverage & Deliverables

Our PDF Reports And Online Dashboard Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

Related Reports

Healthcare ITHealthcare IT

Veterinary Care Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Veterinary Care Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Surgical Imaging Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Surgical Imaging Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Healthcare BPO Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Healthcare BPO Market, focusing on crucial trends, advancement in technology, and the competitive landscape. With an emphasis on..

From $4299

Healthcare ITHealthcare IT

Pen Needles Market Size, Share & Trends Analysis Report

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Pen Needles Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

Energy & PowerEnergy & Power

Petroleum Cargo Inspection and Testing Services Market

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Petroleum Cargo Inspection and Testing Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

Energy & PowerEnergy & Power

Petroleum Cargo Inspection and Testing Services Market

John Doe
13 Nov
5 Min Read

This report delivers comprehensive analysis of Petroleum Cargo Inspection and Testing Market, focusing on crucial trends, advancement in technology, and the competitive...

From $4299

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Autologous Cell Therapy Product Market: Solutions, Growth & Trends | 2025-2035